Clarametyx 2022-008: Immunogenicity screening of three high-dose peptide immunogen concentrations with Alhydrogel®, administered subcutaneously naïve wild type mice

Project Details

StatusFinished
Effective start/end date21/07/22 → 20/07/23

Funding

  • Clarametyx Biosciences, Inc.: $11,162.00